Literature DB >> 9019348

Molecular determinants in the biology of liver metastasis.

R Radinsky1, L M Ellis.   

Abstract

A primary goal of cancer research is an increased understanding of the molecular mechanisms mediating the process of cancer metastasis. Analyses of colon cancer cells (the seeds) and the microenvironment (the soil) has increased our understanding of the biologic mechanisms mediating liver-specific metastasis. Insight into the molecular mechanisms regulating the pathobiology of cancer metastasis as well as a better understanding of the interaction between the metastatic cell and the host environment should produce a foundation for new therapeutic approaches. In this article we summarize experimental observations demonstrating the importance of specific factors that regulate various steps in the metastatic cascade. Furthermore, this article emphasizes the importance of the host organ's microenvironment and its role in liver metastasis formation. The production of metastases depends, in part, on the interaction of particular tumor cells with specific organ environments. Therefore, the successful metastatic cell must be viewed currently as a cell receptive to its environment. The analyses presented herein add important evidence to support the concept that cancer metastasis is not a random process; it is a highly regulated process that can be analyzed on the molecular level. To the clinician, it is readily apparent that by the time metastasis forms, most steps in the metastatic cascade have been completed. Therefore, therapy targeted to downregulate or interrupt the last stages of metastasis, proliferation and angiogenesis, should be the areas of greatest investigation in regards to treating established metastasis, whether they are microscopic or macroscopic.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9019348

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  9 in total

1.  Tumour Microenvironment: Overview with an Emphasis on the Colorectal Liver Metastasis Pathway.

Authors:  Alexandros Giakoustidis; Satvinder Mudan; Thorsten Hagemann
Journal:  Cancer Microenviron       Date:  2014-10-03

2.  A phase I and pharmacokinetic study of afilbercept with FOLFIRI: comparison of Chinese and Caucasian populations.

Authors:  Jianming Xu; Yingxin Li; Xing Sun; Dongsheng Zhang; Rongrui Liu; Samira Ziti-Ljajic; Dongmei Shi; Fengying Xue; Nathalie Le Bail; Ruihua Xu
Journal:  Invest New Drugs       Date:  2017-01-19       Impact factor: 3.850

Review 3.  Exploiting novel molecular targets in gastrointestinal cancers.

Authors:  Wen W Ma; Manuel Hidalgo
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

Review 4.  Incidence and management of ZIv-aflibercept related toxicities in colorectal cancer.

Authors:  Muhammad Wasif Saif; Valerie Relias; Kostas Syrigos; Krishna S Gunturu
Journal:  World J Clin Oncol       Date:  2014-12-10

5.  Divergent and convergent evolution in metastases suggest treatment strategies based on specific metastatic sites.

Authors:  Jessica J Cunningham; Joel S Brown; Thomas L Vincent; Robert A Gatenby
Journal:  Evol Med Public Health       Date:  2015-03-20

6.  Downregulation of miR-145 contributes to lung adenocarcinoma cell growth to form brain metastases.

Authors:  Chunyang Zhao; Yan Xu; Yongqiang Zhang; Weiwei Tan; Jianxin Xue; Zongze Yang; You Zhang; You Lu; Xun Hu
Journal:  Oncol Rep       Date:  2013-09-10       Impact factor: 3.906

Review 7.  Investigation of Metastasis-Related Genes: A Rat Model Mimicking Liver Metastasis of Colorectal Carcinoma.

Authors:  Hassan Adwan; Rania Georges; Asim Pervaiz; Martin R Berger
Journal:  Front Oncol       Date:  2017-07-18       Impact factor: 6.244

8.  Small Interfering RNA in Colorectal Cancer Liver Metastasis Therapy.

Authors:  Junlin Xie; Shubin Wang
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

9.  Role of cancer microenvironment in metastasis: focus on colon cancer.

Authors:  Stéphanie Gout; Jacques Huot
Journal:  Cancer Microenviron       Date:  2008-03-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.